Search - tctmd.com

Displaying 21 - 40 of 118

Sort: Relevancy | Date

News Conference News TCT 2020

Sapien 3 Stroke Rate Perplexes in 1-Year SOLVE-TAVI Results

Michael O'Riordan

October 16, 2020

News Conference News TCT 2020

Large Databases Hint at Sentinel Benefit During TAVR, but Uncertainty Remains

Todd Neale

October 16, 2020

News Conference News TCT 2020

Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II

Todd Neale

October 15, 2020

Presentation TCT 2020

TCT 612: Apical VSD and Left Ventricular Dissection Following Transfemoral Transcatheter Aortic Valve Replacement

Presenter: Malik Shehadeh

October 14, 2020

Presentation TCT 2020

TCT 485: Do Manufacturer's Derived Recommendations Predict Vascular Complications During Transfemoral TAVI Approaches Using Default Proglide Strategy?

Presenter: Beytullah Çakal

October 14, 2020

News Conference News TCT 2019

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

L.A. McKeown

October 09, 2019

News Conference News TCT 2019

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

Todd Neale

September 29, 2019

News Conference News TCT 2019

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

Marcus A. Banks

September 27, 2019

Presentation TCT 2019

30-Day Outcomes From an Early Feasibility Study to Assess the Safety and Effectiveness of a Novel Transfemoral TAVR System for the Treatment of Patients With Symptomatic Severe Aortic Regurgitation

Presenter: Vinod Thourani

September 27, 2019

Presentation TCT 2019

Large-Hole Transfemoral Closure III: The MANTA Device

Presenter: David Wood

September 27, 2019

Presentation TCT 2019

Large-Hole Transfemoral Closure II: The InSeal Device

Presenter: Ran Kornowski

September 27, 2019

Presentation TCT 2019

Large-Hole Transfemoral Closure I: The PerQseal Device

Presenter: Jeffrey Popma

September 27, 2019

Presentation TCT 2019

The Anatomically “Correct” Transfemoral JenaValve TAVR System

Presenter: Hendrik Treede

September 27, 2019

News Conference News TCT 2018

Prosthetic Valve Endocarditis Rate Similarly Low for TAVR vs SAVR

TCT Daily Staff

September 28, 2018

Presentation TCT 2018

Case 5 From Argentina: Transfemoral TAVR Complicated by Stuck Delivery System After Deployment

Presenter: Jorge Cortes Lawrenz, Juan F. Granada, Oscar A. Mendiz, Carlos Cabrera Arroyo, Carlos D Calderas, Anibal A. Damonte, Nabeel Ismaeil

September 24, 2018

Presentation TCT 2018

Case #5: A Case in Which We Pushed the Envelope to Complete a Transfemoral TAVR

Presenter: Philippe Genereux, Josep Rodés-Cabau, Suzanne V. Arnold, Wayne B. Batchelor, Pablo Lamelas, Tullio Palmerini, Shigeru Saito, Tobias Tichelbäcker

September 23, 2018

Presentation TCT 2018

TCT-42: An Early Feasibility Study to Assess Safety and Effectiveness of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients With Symptomatic Severe Aortic Stenosis (AS)

Presenter: David Hildick-Smith, Martin B. Leon, Hendrik Treede

September 21, 2018

News Conference News TCT 2017

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Yael L. Maxwell

November 09, 2017

Presentation TCT 2017

TCT 36: Cerebral Embolic Protection During Transfemoral Aortic Valve Replacement Reduces Death and Stroke Compared to Unprotected Procedure in All Subgroups

Presenter: Reginald I. Low, Michael J. Rinaldi, Julia Seeger

October 31, 2017

Presentation TCT 2017

Case #3 Introduction: Patient With Previous CABG Undergoes Successful Transfemoral TAVR via a Tortuous Aorta; and a Few Hours Later, He Becomes Hypotensive, Complains of Chest Pain, and Has T-Wave Inversion in V1-V3

Presenter: Nick Curzen, Rod H. Stables

October 31, 2017

Advertisement

Sapien 3 Stroke Rate Perplexes in 1-Year SOLVE-TAVI Results

Large Databases Hint at Sentinel Benefit During TAVR, but Uncertainty Remains

Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II

TCT 612: Apical VSD and Left Ventricular Dissection Following Transfemoral Transcatheter Aortic Valve Replacement

TCT 485: Do Manufacturer's Derived Recommendations Predict Vascular Complications During Transfemoral TAVI Approaches Using Default Proglide Strategy?

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

30-Day Outcomes From an Early Feasibility Study to Assess the Safety and Effectiveness of a Novel Transfemoral TAVR System for the Treatment of Patients With Symptomatic Severe Aortic Regurgitation

Large-Hole Transfemoral Closure III: The MANTA Device

Large-Hole Transfemoral Closure II: The InSeal Device

Large-Hole Transfemoral Closure I: The PerQseal Device

The Anatomically “Correct” Transfemoral JenaValve TAVR System

Prosthetic Valve Endocarditis Rate Similarly Low for TAVR vs SAVR

Case 5 From Argentina: Transfemoral TAVR Complicated by Stuck Delivery System After Deployment

Case #5: A Case in Which We Pushed the Envelope to Complete a Transfemoral TAVR

TCT-42: An Early Feasibility Study to Assess Safety and Effectiveness of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients With Symptomatic Severe Aortic Stenosis (AS)

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

TCT 36: Cerebral Embolic Protection During Transfemoral Aortic Valve Replacement Reduces Death and Stroke Compared to Unprotected Procedure in All Subgroups

Case #3 Introduction: Patient With Previous CABG Undergoes Successful Transfemoral TAVR via a Tortuous Aorta; and a Few Hours Later, He Becomes Hypotensive, Complains of Chest Pain, and Has T-Wave Inversion in V1-V3

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content